Anteris Technologies Global AVR
$4.99 −$0.10 (-1.96%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $5.09 +2.00%
Open$5.05
Prev close$5.09
Day range$4.92 – $5.18
Volume1.54M
Market cap$486.49M
P/E (TTM)–
Dividend yield–
AVR Stock News
Headlines matching Anteris Technologies Global or the AVR ticker, most recent first.
- Cantor Fitzgerald Remains a Buy on Anteris Technologies Global Corp. (AVR)
- Wells Fargo Maintains Anteris Technologies Global(AVR.US) With Buy Rating, Maintains Target Price $16
- Analysts Offer Insights on NA Companies: BETA Technologies, Inc. Class A (BETA) and Anteris Technologies Global Corp. (AVR)
- Anteris Technologies Global(AVR.US) 10% Shareholder Sells US$5.79 Million in Common Stock
- TD Cowen Maintains Anteris Technologies Global(AVR.US) With Buy Rating, Maintains Target Price $15
- Analysts Offer Insights on Healthcare Companies: Anteris Technologies Global Corp. (AVR) and Kymera Therapeutics (KYMR)
- Analysts Conflicted on These Healthcare Names: Anteris Technologies Global Corp. (AVR), Lifecore Biomedical (LFCR) and Biogen (BIIB)
- Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL), Cogent Biosciences (COGT) and Anteris Technologies Global Corp. (AVR)
- Analysts Offer Insights on Healthcare Companies: Anteris Technologies Global Corp. (AVR) and Siemens Healthineers AG (OtherSEMHF)
- Barclays Maintains Anteris Technologies Global(AVR.US) With Buy Rating, Raises Target Price to $18 Positive
- Barclays Reaffirms Their Buy Rating on Anteris Technologies Global Corp. (AVR)
- Cantor Fitzgerald Sticks to Their Buy Rating for Anteris Technologies Global Corp. (AVR)
- Anteris Technologies Raised to Buy From Spec Buy by Bell Potter AVR.AU Positive
- Barclays Maintains Anteris Technologies Global(AVR.US) With Buy Rating, Cuts Target Price to $17 Negative
- Wells Fargo Initiates Anteris Technologies Global(AVR.US) With Buy Rating, Announces Target Price $16
No comments yet — be the first to weigh in on AVR.
Sign in to join the discussion.